When investors think of pharmaceutical stocks, they tend to see them as growth opportunities, capitalizing on a collection of novel, game-changing, and often life-saving drugs. Rarely does a steady stream of income factor in to the decision to buy a particular drugmaker’s stock.
But the fact is, many of these companies dole out sizable dividends on a regular basis. Investors seeking cash flow as much as capital growth from the pharmaceutical industry should consider one or two of these five strong dividend stocks from that space. Some of these names might even surprise you: AstraZeneca (AZN) still pays dividends at a rate of 4.9%. Merck (MRK) as the pharmaceutical stock that paid out 3.6% of the stock’s current price in the form of dividends over the past twelve months. Eli Lilly (LLY) out, and it’s too soon to assume its 3.9% dividend yield is going to evaporate. GlaxoSmithKline (GSK) offers the second-biggest payout among the traditional pharmaceutical companies. PDL BioPharma (PDLI) boasts the biggest payout with a whopping yield of 7.4%.
Source: InvestorPlace
Related Articles:
- Investments That Pay Monthly Dividends
- 12 Higher Yielding Stocks With A Low Dividend Payout Ratio
- Early Warning Signs of a Dividend Cut
- Income Annuities vs. Dividend Stocks
- 7 Tech Stocks With A History of Growing Their Dividends
________________________________________________________________
Subscribe to:
Post Comments (Atom)
~
Popular Posts Last 30 Days
-
As a relatively new blogger, the one thing that has stood out in my mind is the number of Canadian bloggers in the areas that I am most inte...
-
In short, dividend-bearing stocks are one of the smartest approaches stock investors have available currently. The same is true in strong ec...
-
If your growth-investing days are over (or nearly so) and you're more interested in steady income, start your search with all-weather st...
-
Even in the current inflationary environment, where stocks across a wide variety of sectors are trading down, companies with a favorable his...
-
Finding cheap dividend stocks is critical for another reason. By the time the Federal Reserve meets for the second time in 2023, the central...
-
Warren Buffett's Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) is crushing the market this year as value and dividend stocks have pulle...
-
Investing in passive income can allow you to make money with minimal portfolio management. There are many types of investments to make passi...
-
ETF investors willing to take higher risk for higher returns might very well be a little miffed. Dividend- and low-volatility exchange trade...
-
Many companies make very predictable fixed dividend payments each quarter. When they do, their investors have a pretty good idea of how much...
-
As 2022 wraps up, many investors are likely looking for ways to position their portfolio for more macroeconomic uncertainty next year. After...
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.